On Monday, Verve Therapeutics Inc (VERV) stock saw a decline, ending the day at $4.5 which represents a decrease of $-0.29 or -6.05% from the prior close of $4.79. The stock opened at $4.85 and ...

Leerink Partners, a leading investment bank specializing in healthcare, is pleased to announce the addition of Holden Hodgson as Senior Managing Director, Derivatives. Mr. Hodgson will be based in the ...